333 related articles for article (PubMed ID: 16022171)
1. Self-designing trial combined with classical group sequential monitoring.
Yin G; Shen Y
J Biopharm Stat; 2005; 15(4):667-75. PubMed ID: 16022171
[TBL] [Abstract][Full Text] [Related]
2. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
Lachin JM
Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
[TBL] [Abstract][Full Text] [Related]
3. A practical comparison of group-sequential and adaptive designs.
Kelly PJ; Sooriyarachchi MR; Stallard N; Todd S
J Biopharm Stat; 2005; 15(4):719-38. PubMed ID: 16022175
[TBL] [Abstract][Full Text] [Related]
4. Increasing the sample size when the unblinded interim result is promising.
Chen YH; DeMets DL; Lan KK
Stat Med; 2004 Apr; 23(7):1023-38. PubMed ID: 15057876
[TBL] [Abstract][Full Text] [Related]
5. Stopping boundaries adjusted for sample size reestimation and negative stop.
Shun Z
J Biopharm Stat; 2002 Nov; 12(4):485-502. PubMed ID: 12477071
[TBL] [Abstract][Full Text] [Related]
6. Issues in designing flexible trials.
Posch M; Bauer P; Brannath W
Stat Med; 2003 Mar; 22(6):953-69. PubMed ID: 12627412
[TBL] [Abstract][Full Text] [Related]
7. Statistical inference for self-designing clinical trials with a one-sided hypothesis.
Shen Y; Fisher L
Biometrics; 1999 Mar; 55(1):190-7. PubMed ID: 11318154
[TBL] [Abstract][Full Text] [Related]
8. Adaptive statistical analysis following sample size modification based on interim review of effect size.
Hung HM; Cui L; Wang SJ; Lawrence J
J Biopharm Stat; 2005; 15(4):693-706. PubMed ID: 16022173
[TBL] [Abstract][Full Text] [Related]
9. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
Lachin JM
Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
[TBL] [Abstract][Full Text] [Related]
10. Adaptive design and estimation in randomized clinical trials with correlated observations.
Yin G; Shen Y
Biometrics; 2005 Jun; 61(2):362-9. PubMed ID: 16011682
[TBL] [Abstract][Full Text] [Related]
11. Sample size re-estimation in group-sequential response-adaptive clinical trials.
Morgan CC
Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
[TBL] [Abstract][Full Text] [Related]
12. Optimal conditional error functions for the control of conditional power.
Brannath W; Bauer P
Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
[TBL] [Abstract][Full Text] [Related]
13. Adaptive group sequential test for clinical trials with changing patient population.
Feng H; Shao J; Chow SC
J Biopharm Stat; 2007; 17(6):1227-38. PubMed ID: 18027228
[TBL] [Abstract][Full Text] [Related]
14. Construction of group sequential designs in clinical trials on the basis of detectable treatment differences.
Schäfer H; Müller HH
Stat Med; 2004 May; 23(9):1413-24. PubMed ID: 15116350
[TBL] [Abstract][Full Text] [Related]
15. Optimization of adaptive designs: efficiency evaluation.
Menon S; Chang M
J Biopharm Stat; 2012; 22(4):641-61. PubMed ID: 22651106
[TBL] [Abstract][Full Text] [Related]
16. Stopping clinical trials early for benefit: impact on estimation.
Freidlin B; Korn EL
Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
[TBL] [Abstract][Full Text] [Related]
17. Standard versus adaptive monitoring procedures: A commentary.
Fleming TR
Stat Med; 2006 Oct; 25(19):3305-12; discussion 3313-4, 3326-47. PubMed ID: 16850447
[TBL] [Abstract][Full Text] [Related]
18. Performance of adaptive sample size adjustment with respect to stopping criteria and time of interim analysis.
Jahn-Eimermacher A; Hommel G
Stat Med; 2007 Mar; 26(7):1450-61. PubMed ID: 16900553
[TBL] [Abstract][Full Text] [Related]
19. A review of methods for futility stopping based on conditional power.
Lachin JM
Stat Med; 2005 Sep; 24(18):2747-64. PubMed ID: 16134130
[TBL] [Abstract][Full Text] [Related]
20. Mid-course sample size modification in clinical trials based on the observed treatment effect.
Jennison C; Turnbull BW
Stat Med; 2003 Mar; 22(6):971-93. PubMed ID: 12627413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
